Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)
Tamsulosin Hydrochloride Capsule
Product Images NDC 71205-688
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 71205-688). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)
Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)
This is a figure and chart that shows the mean change from baseline in Total AUA Symptom Score for three different treatments over the course of 13 weeks. The treatments include O=0O—0-08mg, LNt 0.4mg, and placebo. The chart displays the duration of treatment in weeks and the number of participants for each treatment group.*
Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)
A graph showing the mean increase in peak urine flow rate (in L/Sec) in Study 1. The graph has three treatment groups: 0.4mg, 0.8mg, and placebo, represented by different symbols. The x-axis shows the duration of treatment (in weeks) and the y-axis shows the mean change in urine flow rate (in mL/sec). There are 5 data points on the graph, each representing a different time point during the study.*
Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)
This text explains the results of a study regarding the mean increase in peak urine flow rate. The study is identified as Study 2 and the data is presented in Figure 3B. The graph shows the duration of treatment in weeks on the x-axis and the mean increase in peak urine flow rate in mL/sec on the y-axis. There is also a legend describing the treatment group. However, there is no clear description of what the study was evaluating or what condition the treatment was for.*
71205-688-14 (Tamsulosin Fig6)
This is a description of Tamsulosin HCI 0.4mg capsules, containing 14 capsules per package. The NDC number for this product is 71205-688-14, and it is distributed by Rising Health, LLC. The capsules are olive green and orange and imprinted with "53" and "on." Each capsule contains Tamsulosin hydrochloride USP 0.4mg. This drug is available only with a prescription and should be kept out of reach of children. The capsules should be stored at a temperature of 20°-25°C (68°-77°F).*
Chemical Structure (Tamsulosin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
